AAPLOG

Holland, Michigan—Today the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), together with the Christian Medical Association and Concerned Women for America, filed a response with the FDA to claims of the Population Council, Inc., and Danco Laboratories, LLC. The Population Council holds the U.S. patent on mifepristone and Danco Laboratories distributes mifepristone in the […]

AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA Holland, Michigan—The American Association of Pro-Life Obstetricians and Gynecologists, together with the Christian Medical Association and Concerned Women for America, filed a response on August 20 with the Food & Drug Administration requesting immediate revocation of the approval of Mifeprex (RU-486), the abortion pill. The petition

May 23, 2002 Ralph Hale, M.D. Executive Vice President The American College of Obstetricians and Gynecologists 409 12th Street, S.W. Washington, D.C. 20090-6920 Dear Dr. Hale: We write to object to your prior efforts, purportedly on behalf of the American College of Obstetricians and Gynecologists, to compromise the FDA’s proposed restrictions on the use of

The membership of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) considers it unethical to attempt the cloning of human beings, or to create human embryos via cloning, for any purpose. We believe that a new human life normally begins at conception with the union of an egg from a women and a sperm

THE AMERICAN ASSOCIATION OF PRO LIFE OBSTETRICIANS AND GYNECOLOGISTS Dr. Charles B. Hammond President, ACOG May 2001 Dear Dr. Hammond and ACOG Officers, We would like to express our congratulations to you, Dr. Hammond, as the new president of ACOG. We are aware of, and respect, your reputation as a physician, scientist and educator. We

On September 28, 2000 the United States Food and Drug Administration (FDA) announced the approval of mifepristone, in combination with misoprostol, for early pregnancy termination.1 This decision received the unqualified approval of the American College of Obstetricians and Gynecologists (ACOG). Mifepristone is also known as RU 486 and is marketed in the United States under

AAPLOG Response to ACOG Executive Board Statement of Policy Re: “Partial Birth Abortion,” dated 12 Jan 97. The American Association of ProLife Obstetricians and Gynecologists Feb 1997 Fredric D. Frigoletto, Jr., M.D., President Executive Board American College of Obstetricians and Gynecologists 409 12th Street, SW P.O. Box 96920 Washington, D.C. 20090-6920 Dear Dr. Frigoletto, We

THE AMERICAN ASSOCIATION OF PROLIFE OBSTETRICIANS AND GYNECOLOGISTS HOW ACOG ARRIVED AT THE WORDING OF ITS 1997 D&X POLICY STATEMENT As medical doctor, and especially as an OB/GYN, you will be interested in how the ACOG’s 1997 Policy Statement on D&X came about. The ACOG “select panel” met for only two days to draft the organization’s